vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $66.9M, roughly 1.1× Energy Recovery, Inc.). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -49.0%, a 89.3% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -0.3%). Energy Recovery, Inc. produced more free cash flow last quarter ($6.4M vs $-84.7M).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

ERII vs VRDN — Head-to-Head

Bigger by revenue
VRDN
VRDN
1.1× larger
VRDN
$70.6M
$66.9M
ERII
Growing faster (revenue YoY)
VRDN
VRDN
+81958.4% gap
VRDN
81958.1%
-0.3%
ERII
Higher net margin
ERII
ERII
89.3% more per $
ERII
40.2%
-49.0%
VRDN
More free cash flow
ERII
ERII
$91.2M more FCF
ERII
$6.4M
$-84.7M
VRDN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ERII
ERII
VRDN
VRDN
Revenue
$66.9M
$70.6M
Net Profit
$26.9M
$-34.6M
Gross Margin
67.2%
Operating Margin
46.8%
-56.7%
Net Margin
40.2%
-49.0%
Revenue YoY
-0.3%
81958.1%
Net Profit YoY
14.7%
54.9%
EPS (diluted)
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
VRDN
VRDN
Q4 25
$66.9M
Q3 25
$32.0M
$70.6M
Q2 25
$28.1M
Q4 24
$67.1M
Q3 24
$38.6M
Q2 24
$27.2M
Q1 24
$12.1M
Q4 23
$57.2M
Net Profit
ERII
ERII
VRDN
VRDN
Q4 25
$26.9M
Q3 25
$3.9M
$-34.6M
Q2 25
$2.1M
Q4 24
$23.5M
Q3 24
$8.5M
Q2 24
$-642.0K
Q1 24
$-8.3M
Q4 23
$19.8M
Gross Margin
ERII
ERII
VRDN
VRDN
Q4 25
67.2%
Q3 25
64.2%
Q2 25
64.0%
Q4 24
70.2%
Q3 24
65.1%
Q2 24
64.6%
Q1 24
59.0%
Q4 23
69.1%
Operating Margin
ERII
ERII
VRDN
VRDN
Q4 25
46.8%
Q3 25
11.4%
-56.7%
Q2 25
5.3%
Q4 24
38.2%
Q3 24
18.3%
Q2 24
-7.4%
Q1 24
-90.4%
Q4 23
36.0%
Net Margin
ERII
ERII
VRDN
VRDN
Q4 25
40.2%
Q3 25
12.1%
-49.0%
Q2 25
7.3%
Q4 24
35.0%
Q3 24
22.0%
Q2 24
-2.4%
Q1 24
-68.3%
Q4 23
34.6%
EPS (diluted)
ERII
ERII
VRDN
VRDN
Q4 25
$0.49
Q3 25
$0.07
Q2 25
$0.04
Q4 24
$0.40
Q3 24
$0.15
Q2 24
$-0.01
Q1 24
$-0.14
Q4 23
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$75.2M
$490.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.2M
$503.0M
Total Assets
$231.5M
$577.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
VRDN
VRDN
Q4 25
$75.2M
Q3 25
$70.4M
$490.9M
Q2 25
$79.5M
Q4 24
$78.0M
Q3 24
$118.6M
Q2 24
$101.0M
Q1 24
$117.4M
Q4 23
$108.5M
Stockholders' Equity
ERII
ERII
VRDN
VRDN
Q4 25
$206.2M
Q3 25
$180.8M
$503.0M
Q2 25
$185.2M
Q4 24
$210.0M
Q3 24
$233.9M
Q2 24
$218.5M
Q1 24
$216.0M
Q4 23
$219.8M
Total Assets
ERII
ERII
VRDN
VRDN
Q4 25
$231.5M
Q3 25
$209.6M
$577.1M
Q2 25
$212.3M
Q4 24
$242.8M
Q3 24
$262.7M
Q2 24
$249.0M
Q1 24
$244.3M
Q4 23
$253.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
VRDN
VRDN
Operating Cash FlowLast quarter
$7.1M
$-84.6M
Free Cash FlowOCF − Capex
$6.4M
$-84.7M
FCF MarginFCF / Revenue
9.6%
-120.1%
Capex IntensityCapex / Revenue
1.0%
0.2%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
VRDN
VRDN
Q4 25
$7.1M
Q3 25
$-3.1M
$-84.6M
Q2 25
$4.1M
Q4 24
$9.0M
Q3 24
$-3.0M
Q2 24
$8.1M
Q1 24
$6.5M
Q4 23
$13.8M
Free Cash Flow
ERII
ERII
VRDN
VRDN
Q4 25
$6.4M
Q3 25
$-3.5M
$-84.7M
Q2 25
$4.0M
Q4 24
$8.9M
Q3 24
$-3.2M
Q2 24
$7.9M
Q1 24
$5.7M
Q4 23
$12.4M
FCF Margin
ERII
ERII
VRDN
VRDN
Q4 25
9.6%
Q3 25
-10.9%
-120.1%
Q2 25
14.3%
Q4 24
13.2%
Q3 24
-8.2%
Q2 24
28.9%
Q1 24
46.9%
Q4 23
21.7%
Capex Intensity
ERII
ERII
VRDN
VRDN
Q4 25
1.0%
Q3 25
1.1%
0.2%
Q2 25
0.5%
Q4 24
0.2%
Q3 24
0.4%
Q2 24
0.7%
Q1 24
6.8%
Q4 23
2.4%
Cash Conversion
ERII
ERII
VRDN
VRDN
Q4 25
0.26×
Q3 25
-0.81×
Q2 25
2.02×
Q4 24
0.38×
Q3 24
-0.35×
Q2 24
Q1 24
Q4 23
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons